Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

SciSparc Ltd.

SPRCNASDAQ
Healthcare
Biotechnology
$5.06
$4.56(911.60%)
U.S. Market is Open • 15:37

SciSparc Ltd. Fundamental Analysis

SciSparc Ltd. (SPRC) shows weak financial fundamentals with a PE ratio of -0.02, profit margin of -13.13%, and ROE of -3.30%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position623.38%
PEG Ratio-0.00

Areas of Concern

ROE-3.30%
Operating Margin-21.57%
Current Ratio0.55
We analyze SPRC's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1593.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1593.1/100

We analyze SPRC's fundamental strength across five key dimensions:

Efficiency Score

Weak

SPRC struggles to generate sufficient returns from assets.

ROA > 10%
-2.37%

Valuation Score

Excellent

SPRC trades at attractive valuation levels.

PE < 25
-0.02
PEG Ratio < 2
-0.00

Growth Score

Moderate

SPRC shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

SPRC shows balanced financial health with some risks.

Debt/Equity < 1
-3.14
Current Ratio > 1
0.55

Profitability Score

Weak

SPRC struggles to sustain strong margins.

ROE > 15%
-330.17%
Net Margin ≥ 15%
-13.13%
Positive Free Cash Flow
No

Key Financial Metrics

Is SPRC Expensive or Cheap?

P/E Ratio

SPRC trades at -0.02 times earnings. This suggests potential undervaluation.

-0.02

PEG Ratio

When adjusting for growth, SPRC's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values SciSparc Ltd. at -0.32 times its book value. This may indicate undervaluation.

-0.32

EV/EBITDA

Enterprise value stands at 0.06 times EBITDA. This is generally considered low.

0.06

How Well Does SPRC Make Money?

Net Profit Margin

For every $100 in sales, SciSparc Ltd. keeps $-13.13 as profit after all expenses.

-13.13%

Operating Margin

Core operations generate -21.57 in profit for every $100 in revenue, before interest and taxes.

-21.57%

ROE

Management delivers $-3.30 in profit for every $100 of shareholder equity.

-3.30%

ROA

SciSparc Ltd. generates $-2.37 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.37%

Following the Money - Real Cash Generation

Operating Cash Flow

SciSparc Ltd. generates limited operating cash flow of $-4.77M, signaling weaker underlying cash strength.

$-4.77M

Free Cash Flow

SciSparc Ltd. generates weak or negative free cash flow of $-4.77M, restricting financial flexibility.

$-4.77M

FCF Per Share

Each share generates $-9.16 in free cash annually.

$-9.16

FCF Yield

SPRC converts -19.22% of its market value into free cash.

-19.22%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.02

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.32

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.27

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-3.14

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.55

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-3.30

vs 25 benchmark

ROA

Return on assets percentage

-2.37

vs 25 benchmark

ROCE

Return on capital employed

-197.96

vs 25 benchmark

How SPRC Stacks Against Its Sector Peers

MetricSPRC ValueSector AveragePerformance
P/E Ratio-0.0229.93 Better (Cheaper)
ROE-330.17%773.00% Weak
Net Margin-1312.84%-22993.00% (disorted) Weak
Debt/Equity-3.140.25 Strong (Low Leverage)
Current Ratio0.556.10 Weak Liquidity
ROA-236.82%-18195.00% (disorted) Weak

SPRC outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews SciSparc Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ